(Q53977176)

23 May 2018

title

Pharmacological properties of nebivolol in man. (English)

1 reference

23 May 2018

1 reference

1 reference

L M Van Bortel

1

1 reference

23 May 2018

J N de Hoon

2

1 reference

23 May 2018

M J Kool

3

1 reference

23 May 2018

J A Wijnen

4

1 reference

23 May 2018

C I Vertommen

5

1 reference

23 May 2018

L G Van Nueten

6

1 reference

23 May 2018

publication date

1 January 1997

1 reference

23 May 2018

European Journal of Clinical Pharmacology

published in

1 reference

23 May 2018

volume

51

1 reference

23 May 2018

issue

5

1 reference

23 May 2018

page(s)

379-384

1 reference

23 May 2018

https://scigraph.springernature.com/pub.10.1007/s002280050217

exact match

0 references

cites work

The assessment of beta-adrenoceptor blocking drugs in man

1 reference

https://api.crossref.org/works/10.1007%2FS002280050217

Effects of ICI 141,292 on exercise tachycardia and isoprenaline-induced beta-adrenoceptor responses in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050217

Observations on the mechanism underlying the differences in exercise and isoprenaline tachycardia after cardioselective and non-selective beta-adrenoceptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050217

Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050217

A pragmatic approach to the pressor dose-response as an index of vascular reactivity and adrenoceptor function in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050217

The pressor dose-response in clinical cardiovascular pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050217

Nitric oxide mediated venodilator effects of nebivolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050217

A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050217

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002280050217

Beta-blockers for heart failure: where are we now?

21 January 2018

1 reference

12 December 2020

Administration of nebivolol after coronary artery bypass in patients with altered left ventricular function

1 reference

12 December 2020

A standardized isoproterenol sensitivity test. The effects of sinus arrhythmia, atropine, and propranolol

1 reference

12 December 2020

Exercise tolerance with nebivolol and atenolol

1 reference

12 December 2020

Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life

1 reference

12 December 2020

Medium-term effects of beta-blockade on left ventricular mechanics: a double-blind, placebo-controlled comparison of nebivolol and atenolol in patients with ischemic left ventricular dysfunction

1 reference

12 December 2020

Potential use of third-generation beta-blockers in heart failure

1 reference

12 December 2020

Intravenously Administered Isoproterenol Sulfate Dose-Response Curves in Man

1 reference

12 December 2020

Effects of D-nebivolol and L-nebivolol on left ventricular systolic and diastolic function: comparison with D-L-nebivolol and atenolol.

1 reference

12 December 2020

Nebivolol vasodilates human forearm vasculature: evidence for an L-arginine/NO-dependent mechanism

1 reference

12 December 2020

Nebivolol Induces Endothelium Dependent Relaxatíons of Canine Coronary Arteries

1 reference

12 December 2020

Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy

1 reference

12 December 2020

Comparison of bisoprolol with other beta-adrenoceptor blocking drugs

1 reference

12 December 2020

Treatment of ambulatory hypertensives with nebivolol or hydrochlorothiazide alone and in combination. A randomized, double-blind, placebo-controlled, factorial-design trial

1 reference

12 December 2020

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

12 December 2020

Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist.

1 reference

12 December 2020

Identifiers

DOI

10.1007/S002280050217

1 reference

23 May 2018

1 reference

23 May 2018